Cancer Genetics Inc (NASDAQ:CGIX)

10.53
Delayed Data
As of Apr 17
 +0.28 / +2.73%
Today’s Change
4.83
Today|||52-Week Range
16.88
+57.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-2.5M-4.2M-4.8M--
 
 
 
 
Depreciation103.5K124.4K279.9K--
 
 
 
 
Total Other Cash Flow893.2K813.4K1.1M--
 
 
 
 
Funds From Operations-1.5M-3.2M-3.5M--
 
 
 
 
Funds From/For Other Operating Expenses447.7K627.1K-1.4M--
 
 
 
 
Net Cash Flow - Operating Activities-1.9M-3.9M-2.1M-4.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-1.0M--
 
 
Capital Expenditures-144.0K-241.1K-559.3K--
 
 
 
 
Net Assets From Acquisitions 0.000.00-3.2M--
 
 
Other Investing - Uses-6.0M0.000.00--
 
 
Net Cash Flow Investing-6.2M-267.0K-4.5M-463.2K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-29.8K-5.4K-113.9K--
 
 
 
 
Net Proceeds Stock Sale3.0K251.1K3.1K--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-26.8K245.7K-110.8K-303.1K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-8.1M-3.9M-6.7M-5.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account